Selecting a patient
cutaneous wart lesions, cancer, Immunosuppressed, chronic disease
WARTS, DISEASE, CANCER, CHRONIC DISEASE
Fifty people, including 21 males and 29 females, participated in the study. They lost by a count of 10 because the treatment was too disruptive to their productivity. In total, 204 cutaneous wart lesions were treated across 40 individuals (14 males and 26 females) in this randomized controlled experiment. Patients’ ages ranged from 20 months to 52 years. Patients were included who had single or multiple cutaneous warts matching the diagnostic criteria. Women who are pregnant are not eligible. Immunosuppressed patients (related to systemic corticosteroids, chemotherapy, cancer, transplant patients, etc.). Patients had utilized non‐study treatments within the month prior to the study.At the first appointment, patients and their guardians were asked detailed questions about their medical history, including, but not limited to, name, age, sex, occupation, financial status, disease duration, lesion location, lesion count, single versus multiple lesion status, and whether or not they had previously received treatment for their warts. Prior treatment with corticosteroids or other immune suppressants, a history of warts in the family, or a diagnosis of immune suppression, organ transplant, or chronic disease should be considered.Patients who met the inclusion and exclusion criteria underwent a thorough physical examination to determine the location, size, type, and number of lesions. Every patient was given a set of color photos taken at the start and before each treatment.